Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Troponin, or the troponin complex, is a complex of three regulatory proteins (troponin C, troponin I, and troponin T) that is integral to muscle contraction in skeletal muscle and cardiac muscle, but not smooth muscle.
Discussions of troponin often pertain to its functional characteristics and/or to its usefulness as a diagnostic marker or therapeutic target for various heart disorders in particular as a highly specific marker for myocardial infarction or heart muscle cell death.
A troponin test measures the levels troponin T or troponin I proteins in the blood. These proteins are released when the heart muscle has been damaged, such as occurs with a heart attack.
Scope of the Report:
The classification of Troponin includes Troponin I (TnI), Troponin T (TnT), the sales of Troponin I (TnI) are 181 million units, with its market share 80.6%. In addition, the sales market share of Troponin T (TnT) is 19.4% in 2017.
North America region is the largest supplier of Troponin, with a production market share nearly 47.2% in 2017. Europe is the second largest supplier of Troponin, enjoying revenue market share nearly 36.2% in 2017.
North America is the largest sales place, with market share nearly 41.5% in 2017. Following North America, China is the second largest sales place with the sales market share of 19.7% in 2017.
The worldwide market for Troponin is expected to grow at a CAGR of roughly 9.5% over the next five years, will reach 1820 million US$ in 2024, from 1050 million US$ in 2019, according to a new WMR study.
This report focuses on the Troponin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Troponin I (TnI)
Troponin T (TnT)
Market Segment by Applications, can be divided into
Acute Coronary Syndrome
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Troponin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Troponin, with price, sales, revenue and global market share of Troponin in 2017 and 2018.
Chapter 3, the Troponin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Troponin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Troponin market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Troponin sales channel, distributors, customers, research findings and conclusion, appendix and data source.